Kentucky man files Invokana lawsuit claiming damages due to diabetic ketoacidosis side effects.
A lawsuit has been filed against Invokana’s manufacturers Johnson & Johnson, its Janssen subsidiary, and Mitsubishi Tanabe Pharma Corp in the U.S. District Court for the District of New Jersey. In the suit, plaintiff Ricky Bowling of Kentucky claims he suffered damages from side effects he experienced when using the new generation diabetes medication. Bowling alleges that he suffered serious complications from a build up of acid ketones in the blood, known as diabetic ketoacidosis. According to Bowling’s Invokana lawsuit, the medicine’s manufacturers failed to research Invokana’s side effects or warn patients and doctors about the increased risk of diabetic ketoacidosis. What is Diabetic Ketoacidosis (DKA)? DKA develops when your body can’t produce enough insulin. Insulin has a key role in helping sugar or glucose, a major source of energy for muscles and other tissues enter cells. Without enough insulin, the body begins to break down fat as fuel. This process leads to a buildup of acids in the bloodstream called ketones, eventually leading to diabetic ketoacidosis if untreated. Usually when a patient develops diabetic ketoacidosis complications, they have to be hospitalized for treatments involving intravenous fluids and insulin. In severe cases, DKA can be life threatening and cause wrongful death. Invokana Ketoacidosis Side Effects Johnson & Johnson’s Invokana was cleared for sale by the FDA in 2013. The FDA has issued several warning label changes and many injured plaintiffs are filing personal injury and product liability claims for Invokana ketoacidosis side effects. What is Invokana? Invokana (canagliflozin) is the first in a new class of diabetes drugs, known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. Invokana Ketoacidosis Risks The FDA has received many Invokana related adverse event reports. In May 2015, the FDA investigated the link between Invokana and ketoacidosis after discovering many reports of ketoacidosis. Ketoacidosis complications are not unique to Invokana, other SGLT2 inhibitors including Invokamet, Farxiga, Xigduo XR, Jardiance and Glyxambi are also plagued with similar side effects. Originally posted by Shezad Malik MD JD on the online version of The Legal Examiner. Invokana Lawsuit – Ball & Bonholtzer Trial Attorney – Los Angeles